Jan Verbeek - Concepedia

Author

Jan Verbeek

Also Known As

J Verbeek, J. Verbeek, J.F.M. Verbeek, Jan F M Verbeek, Jan F. M. Verbeek, Jan F. Verbeek, Jan F.M. Verbeek, Jan FM Verbeek, Jan Verbeek, Verbeek, J.

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Radboud University Nijmegen Radboud University Medical Center Singapore General Hospital University of Cambridge

About

Jan Verbeek is an author at Erasmus MC specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	549
2	Public Health	4	4	319
3	Biostatistics	4	4	327
4	Health Sciences	2	2	61
5	Engineering	1	1	26

Jan Verbeek

Publications

923

Citations

H-Index

Page 1

	Year	Citations
Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators Arnout R. Alberts, Monique J. Roobol, Jan Verbeek, European Urology UrologyMedical ImagingCancer DetectionCancer ScreeningMedicine	2018	190
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth Monique J. Roobol, Jan Verbeek, Theodorus van der Kwast, European Urology UrologyUrologic Cancer EpidemiologyGenitourinary CancerCribriform GrowthCancer Screening	2017	82
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. R E van Rijswijk, C. Haanen, AW Dekker, Journal of Clinical Oncology Radiation TherapyOptimal DosageMedicineCancer ManagementPharmacology	1989	73
Major complications and causes of death in patients treated for Hodgkin's disease. R E van Rijswijk, Jan Verbeek, C. Haanen, Journal of Clinical Oncology Palliative CareOncologyModality TherapyTreatment ModalityImmunodeficiencies	1987	61
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease Ivo G. Schoots, Daniël F. Osses, Frank‐Jan H. Drost, Translational Andrology and Urology	2018	52
Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary? Daniël F. Osses, Frank‐Jan H. Drost, Jan Verbeek, British Journal of Urology	2020	51
Leveraging the blue economy to transform marine forest restoration Karen Filbee‐Dexter, Thomas Wernberg, Rodolfo Barreiro, Journal of Phycology	2022	50
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy Christophe K. Mannaerts, Maudy Gayet, Jan Verbeek, European Urology Oncology UrologyFusion BiopsyBiopsy-naïve PatientsMedical ImagingGenitourinary Cancer	2018	45
Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome Nuno Pereira‐Azevedo, Jan Verbeek, Daan Nieboer, Translational Andrology and Urology	2018	37
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative Arveen Kalapara, Jan Verbeek, Daan Nieboer, European Urology Oncology UrologyPreventive MedicineHealth PolicyActive Surveillance ProtocolsCancer Screening	2019	37

Page 1